Chewable DGL

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
29-08-2019

有効成分:

Glycyrrhiza glabra, Quantity: 400 mg (Equivalent: Glycyrrhiza glabra, Qty 4 g)

から入手可能:

Factors Group Australia Pty Ltd

医薬品形態:

Tablet, chewable

構図:

Excipient Ingredients: silicon dioxide; magnesium stearate; stearic acid; Aniseed Powder; microcrystalline cellulose; xylitol; Stevia rebaudiana

投与経路:

Oral

適応症:

Anti-inflammatory/relieve inflammation ; Demulcent/soothe irritated tissues ; Decrease/reduce/relieve abdominal pain/discomfort ; Decrease/reduce/relieve symptoms of heartburn ; Helps decrease/reduce/relieve mild gastrointestinal tract inflammation ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve throat mucous membrane irritation/inflammation

製品概要:

Visual Identification: ;

認証ステータス:

Listed

承認日:

2019-07-31

ドキュメントの履歴を表示する